COMMUNIQUÉS West-GlobeNewswire

Zealand Pharma - Transactions related to share buy-back program (weeks 19-20, 2026)
14/05/2026
Company announcement No. 16 / 2026 Zealand Pharma - Transactions related to share buy-back program (weeks 19-20, 2026) Copenhagen, Denmark, May 14, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: [...]
DentPrime Introduces an “International Complication Protection Program” for Overseas Dental Patients
14/05/2026
New initiative to increase patient confidence and long-term aftercare support in international dental treatment ANTALYA, Türkiye, May 14, 2026 (GLOBE NEWSWIRE) -- As dental tourism grows internationally for patients [...]
Terumo Neuro Announces Publication of Landmark RAGE Study Results for HydroCoil™ Embolic System Coils for Ruptured Intracranial Aneurysms
14/05/2026
Largest prospective, core lab–adjudicated trial in North America confirms strong occlusion, low rebleeding, and favorable functional independence Aliso Viejo, CA, May 14, 2026 (GLOBE NEWSWIRE) -- Terumo Neuro, a global [...]
Imviva Biotech Presents Data Demonstrating Durable Clinical Responses from Ongoing Phase 1/2 Study of CTA313 in Systemic Lupus Erythematosus at ASGCT 2026
14/05/2026
100% of patients treated with CTA313 achieved an SRI-4 response, with half achieving remission BOSTON, May 14, 2026 (GLOBE NEWSWIRE) -- Imviva Biotech, a clinical-stage biotechnology company developing next-generation [...]
Rarecells Recognized Among Top 5 Disruptive Health Technologies with the Potential to Change the World by Maynooth University’s Innovation Value Institute
14/05/2026
NEW YORK and PARIS, May 14, 2026 (GLOBE NEWSWIRE) -- Rarecells, a pioneer in liquid biopsy technologies for early cancer detection, today announced that its proprietary ISET® diagnostic system has been recognized by the [...]
Biodexa issues letter to Shareholders
14/05/2026
May 14, 2026 Biodexa issues letter to Shareholders Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing innovative products focused on the treatment or prevention of [...]
Easy Environmental Solutions & Terreplenish® Show Outstanding Yield Increases & Offer Alternative To Petroleum-Based Fertilizers
14/05/2026
Terreplenish® leads the way as company responds to worldwide nitrogen shortage MANKATO, Minn., May 14, 2026 (GLOBE NEWSWIRE) -- Easy Environmental Solutions, Inc. (OTC: EZES) continues to offer a true solution to the [...]
Dogwood Therapeutics Announces First Quarter 2026 Financial Results
14/05/2026
- Halneuron ® Phase 2b trial in Chemotherapy Induced Neuropathy on track for top-line results in fall 2026 - - FDA acceptance of SP16 Investigational New Drug Application for the treatment of Chemotherapy Induced Pain [...]
Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
14/05/2026
MONTREAL and CHARLOTTE, N.C., May 14, 2026 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular [...]
20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026
14/05/2026
GAITHERSBURG, Md., May 14, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (“20/20”) (Nasdaq: AIDX), an early market entrant in cutting-edge, AI powered laboratory-based blood tests for the early detection and prevention [...]
Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment
14/05/2026
First-of-its-kind partnership expands NeuroStar platform capabilities with advanced visualization technology designed to address evolving provider needs and support more personalized treatment planning MALVERN, Pa., May [...]
Biogen Completes Acquisition of Apellis Pharmaceuticals
14/05/2026
CAMBRIDGE, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc. (Nasdaq: APLS). Apellis, a leader in advancing [...]
GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline
14/05/2026
Phase 2a data show zero cough and 60% lower treatment-related diarrhea than placebo despite higher nintedanib use in the active arm – suggesting GRI-0621 may mitigate nintedanib-related GI-toxicities when used in [...]
Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program
14/05/2026
Following a Type B meeting with FDA, Senti Bio plans to proceed with a single-arm multi-center registrational trial for SENTI-202, building off the strong Phase 1 clinical results demonstrating deep and durable MRD- [...]
AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer
14/05/2026
Positive Data from Named Patient Program and Positive Interim Data from Ongoing Phase 2 Clinical Trial Segment featuring Professor Doctor Casper H.J. van Eijck, Professor and Pancreato-biliary Surgeon at Erasmus MC and [...]
Silexion Therapeutics Reports Positive Preliminary Immunotherapy Findings for SIL204 in KRAS-Driven Pancreatic Cancer
14/05/2026
Preliminary results from a preclinical study demonstrated statistically significant increase in MHC-I expression following SIL204 treatment in human pancreatic and non-small cell lung cancer cells harboring a KRAS [...]
Polaryx Therapeutics Receives GHP Magazine’s Healthcare & Pharmaceuticals Awards
14/05/2026
Company selected as Best Pediatric Lysosomal Storage Disease Therapeutics and Rare Neurodegenerative Disease Drug Development Excellence Award Winner PARAMUS, NJ, May 14, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics ( [...]
TOMI Environmental Solutions, Inc. Announces Second SteraMist Hybrid System Installation Contract with a World-Renowned East Coast Research University
14/05/2026
FREDERICK, Md., May 14, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announce that we have been awarded the [...]
Sonablate Launches SONA FUSION Global Registry to Advance Precision Sound Medicine and Define Future Standards in Focal Therapy
14/05/2026
First multinational initiative dedicated to long-term HIFU outcomes in prostate cancer and BPH aims to help close the evidence gap in incision-free prostate care CHARLOTTE, N.C., May 14, 2026 (GLOBE NEWSWIRE) -- [...]

Pages